Predictive validity and interrater reliability of the FACE-CARAS toolkit in a CAMHS setting.


Journal

Criminal behaviour and mental health : CBMH
ISSN: 1471-2857
Titre abrégé: Crim Behav Ment Health
Pays: England
ID NLM: 9309668

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 28 03 2018
revised: 24 08 2018
accepted: 04 12 2018
pubmed: 4 1 2019
medline: 9 3 2019
entrez: 4 1 2019
Statut: ppublish

Résumé

The FACE-CARAS (Functional Analysis in Care Environments-Child and Adolescent Risk-Assessment Suite) toolkit has been developed to support practitioners in Child and Adolescent Mental Health Services (CAMHS) in performing a structured risk assessment. It covers a number of risk domains including violence, suicide, self-harm, experienced abuse, and exploitation. Interrater and internal reliability has already been established but not predictive validity. Our aim was to establish the predictive validity of the FACE-CARAS in a CAMHS population. Records from 123 young people with FACE-CARAS ratings completed by clinicians were examined in a retrospective file review to extract data on a relevant list of adverse outcomes at three and at 6 months following the assessment. Although this was not a prospective longitudinal study, researchers were blind to the clinicians' ratings, allowing valid testing of predictive power. Cases were drawn from across generic and specialist CAMHS teams in approximately equal proportions. Data were analysed using receiver operator characteristic statistics. Areas under the curve values in five of the seven risk areas approached or were greater than 0.8 indicated that the FACE-CARAS profile score was a good potential predictor of risks of self-harm, suicidal behaviours, serious self-neglect, abuse or exploitation by others, and violence to others at both 3 and 6 months. It was weakly "predictive" of accidental self-harm and no better than chance at signalling physical ill health. Findings support the use of the "profile summary" section of the tool as likely to generate clinically useful risk predictions. We were concerned that clinical use of the scale did not conform to research standards and often left subscales incompletely rated; however, the fact that the tool nonetheless proved a good predictor of most key adversities under scrutiny may add weight to its value in clinical practice. Further work with the FACE-CARAS subscales is recommended.

Sections du résumé

BACKGROUND BACKGROUND
The FACE-CARAS (Functional Analysis in Care Environments-Child and Adolescent Risk-Assessment Suite) toolkit has been developed to support practitioners in Child and Adolescent Mental Health Services (CAMHS) in performing a structured risk assessment. It covers a number of risk domains including violence, suicide, self-harm, experienced abuse, and exploitation. Interrater and internal reliability has already been established but not predictive validity.
AIMS/HYPOTHESIS OBJECTIVE
Our aim was to establish the predictive validity of the FACE-CARAS in a CAMHS population.
METHODS METHODS
Records from 123 young people with FACE-CARAS ratings completed by clinicians were examined in a retrospective file review to extract data on a relevant list of adverse outcomes at three and at 6 months following the assessment. Although this was not a prospective longitudinal study, researchers were blind to the clinicians' ratings, allowing valid testing of predictive power. Cases were drawn from across generic and specialist CAMHS teams in approximately equal proportions. Data were analysed using receiver operator characteristic statistics.
RESULTS RESULTS
Areas under the curve values in five of the seven risk areas approached or were greater than 0.8 indicated that the FACE-CARAS profile score was a good potential predictor of risks of self-harm, suicidal behaviours, serious self-neglect, abuse or exploitation by others, and violence to others at both 3 and 6 months. It was weakly "predictive" of accidental self-harm and no better than chance at signalling physical ill health.
CONCLUSIONS CONCLUSIONS
Findings support the use of the "profile summary" section of the tool as likely to generate clinically useful risk predictions. We were concerned that clinical use of the scale did not conform to research standards and often left subscales incompletely rated; however, the fact that the tool nonetheless proved a good predictor of most key adversities under scrutiny may add weight to its value in clinical practice. Further work with the FACE-CARAS subscales is recommended.

Identifiants

pubmed: 30604904
doi: 10.1002/cbm.2104
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-56

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Stephen A Evans (SA)

Forensic Child and Adolescent Mental Health Service, NHS GGC Children and Young People's Specialist Services, West Glasgow Ambulatory Care Hospital, Glasgow, UK.

David Young (D)

Department of Mathematics and Statistics, University of Strathclyde and NHS, Greater Glasgow and Clyde, Glasgow, UK.

Paul A Tiffin (PA)

Mental Health and Addiction Research Group, Department of Health Sciences, Faculty of Science, Alcuin Research Resource Centre, University of York, York, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH